Hematological Indices and Sympathetic Block Response in Neuropathic Pain

Sponsor
Ankara City Hospital Bilkent
Study ID
NCT07596823
Status
Recruiting
Apply to this trial

Conditions

  • Neuropathic Pain
  • Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This prospective observational study aims to evaluate the relationship between hematological inflammatory indices and clinical treatment response in patients with neuropathic pain undergoing sympathetic nerve block procedures as part of routine clinical care. Hematological parameters including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), aggregate index of systemic inflammation (AISI), and red cell distribution width (RDW) will be evaluated before and after treatment. The association between changes in these indices and pain outcomes will be analyzed.

Key Dates

First listed
May 19, 2026
Start date
Jun 1, 2026
Status verified
May 2026
Primary completion
Dec 31, 2026
Completion
Jan 31, 2027

Study Design

Enrollment
120 participants (estimated)

Arms

  • Arm: Neuropathic Pain Cohort
    Adult patients diagnosed with neuropathic pain undergoing sympathetic nerve block procedures as part of routine clinical care in the Algology Clinic of Ankara Bilkent City Hospital.

Primary Outcome Measure

Treatment Response at Month 3 [ Time Frame: 3 th month ]

Central Contacts

Related Studies